Cargando…
Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer
Selective estrogen receptor modulators (SERMs) such as tamoxifen have proven to be effective in the treatment of estrogen receptor (ER) positive breast cancer. However, a major obstacle for such endocrine therapy is estrogen independent growth, leading to resistance, and the underlying mechanism is...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546148/ https://www.ncbi.nlm.nih.gov/pubmed/34697301 http://dx.doi.org/10.1038/s41419-021-04288-1 |